ASTELLAS PHARMA

🇯🇵Japan

Country: 🇯🇵Japan

Ownership: -

Established: 2005-01-01

Employees: -

Market Cap: $22.5B

Website: https://www.astellas.com/

Clinical Trials

A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K

Phase 1

Completed

Conditions: Healthy Subjects
Pharmacokinetics of ASP015K

Interventions: Drug: ASP015K
Drug: Placebo

First Posted Date: 2011-07-04

Last Posted Date: 2011-07-04

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 72

Registration Number: NCT01387087

Locations: 🇺🇸
Prism Research, St. Paul, Minnesota, United States
🇺🇸
Clinical Pharmacology of Miami, Miami, Florida, United States

A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of ASP1941 in Healthy Male Taiwanese Subjects

Phase 1

Completed

Conditions: Healthy
Pharmacokinetics of ASP1941

Interventions: Drug: Placebo
Drug: ASP1941

First Posted Date: 2011-06-14

Last Posted Date: 2011-10-12

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 56

Registration Number: NCT01373060

A Study to Assess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical Prostatectomy

Phase 4

Completed

Conditions: Urinary Incontinence

Interventions: Drug: Placebo
Drug: solifenacin succinate

First Posted Date: 2011-06-13

Last Posted Date: 2024-11-21

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 640

Registration Number: NCT01371994

Locations: 🇺🇸
Methodist Hospital Research Institute, Houston, Texas, United States
🇺🇸
Virginia Mason Medical Center, Seattle, Washington, United States
🇺🇸
Swedish Urology Group, Seattle, Washington, United States

and more 57 locations

A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K

Phase 1

Completed

Conditions: Healthy Subjects
Pharmacokinetics of ASP015K
Pharmacodynamics

Interventions: Drug: ASP015K
Drug: Placebo

First Posted Date: 2011-06-03

Last Posted Date: 2011-06-03

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 48

Registration Number: NCT01364974

Locations: 🇺🇸
DaVita Clinical Research, Minneapolis, Minnesota, United States

Pharmacokinetic Interaction Study to Assess the Effect of ASP015K on Mycophenolate Mofetil in Healthy Volunteers

Phase 1

Completed

Conditions: Healthy Subjects
Drug Interactions
Pharmacokinetics of ASP015K

Interventions: Drug: ASP015K
Drug: Mycophenolate Mofetil

First Posted Date: 2011-06-03

Last Posted Date: 2011-06-03

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 24

Registration Number: NCT01364987

Locations: 🇺🇸
Clinical Pharmacology of Miami, Miami, Florida, United States

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

Phase 4

Completed

Conditions: Kidney Transplantation

Interventions: Drug: Advagraf
Drug: Mycophenolate Mofetil
Drug: Sirolimus
Drug: Corticosteroids

First Posted Date: 2011-06-02

Last Posted Date: 2024-10-31

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 853

Registration Number: NCT01363752

Locations: 🇹🇷
3042, Istanbul, Turkey
🇦🇺
5042, New Lambton, Australia
🇦🇺
5043, Perth, Australia

and more 55 locations

Phase I/II Study of ASP9521 in Castrate-Resistant Prostate Cancer (CRPC) Patients

Phase 1

Terminated

Conditions: Castrate Resistant Prostate Cancer

Interventions: Drug: ASP9521

First Posted Date: 2011-05-11

Last Posted Date: 2014-03-24

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 13

Registration Number: NCT01352208

Locations: 🇫🇷
Site: 121, Villejuif, France
🇬🇧
Site:109, Glasgow, United Kingdom
🇧🇪
Site 131, Antwerp, Belgium

and more 1 locations

A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients

Phase 3

Terminated

Conditions: Lupus Nephritis

Interventions: Drug: tacrolimus placebo
Drug: tacrolimus capsule
Drug: leflunomide placebo
Drug: leflunomide tablet
Drug: prednisone

First Posted Date: 2011-04-26

Last Posted Date: 2014-10-17

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 84

Registration Number: NCT01342016

A Study to Assess the Receptor Occupancy of CD86 and CD80 in Subjects With Rheumatoid Arthritis Initiating Abatacept

Completed

Conditions: Rheumatoid Arthritis

Interventions: Drug: abatacept

First Posted Date: 2011-04-20

Last Posted Date: 2011-11-29

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 26

Registration Number: NCT01339481

Locations: 🇺🇸
Pinnacle Research Group, LLC, Anniston, Alabama, United States
🇺🇸
The Center for Rheumatology and Bone Research, Wheaton, Maryland, United States
🇺🇸
Arthritis Research of Florida, Palm Harbor, Florida, United States

and more 4 locations

A Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver Transplantation

Phase 4

Completed

Conditions: Liver Transplantation

Interventions: Drug: Prograf
Drug: Advagraf

First Posted Date: 2011-04-20

Last Posted Date: 2017-07-19

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 100

Registration Number: NCT01339468

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy